Impact of Obesity on the Metabolic Control of Type 2 Diabetes: Results of the Turkish Nationwide Survey of Glycemic and Other Metabolic Parameters of Patients with Diabetes Mellitus (TEMD Obesity Study)

Basit Öğe Kaydı
dc.authoridYildiz, Bulent/0000-0003-1797-7662
dc.authoridAKIN, SAFAK/0000-0003-3886-0500
dc.authoridSahin, Ibrahim/0000-0002-6231-0034
dc.authoridKirac, Cem/0000-0002-0249-9867
dc.authoridBALCI, Mustafa Kemal/0000-0002-6494-3249
dc.authoridDemirci, Ibrahim/0000-0003-0498-3115
dc.authoridBaldane, Suleyman/0000-0002-7001-4075
dc.authorwosidDurmuş, Elif Tutku/IVV-0483-2023
dc.authorwosidturker, fulya/HDM-8773-2022
dc.authorwosidhaymana, cem/Y-6947-2019
dc.authorwosidCesur, Mustafa/AAK-8083-2020
dc.authorwosidYildiz, Bulent/ABD-7781-2020
dc.authorwosidAKIN, SAFAK/E-9456-2013
dc.authorwosidsalman, serpil/GRX-8413-2022
dc.contributor.authorSonmez, Alper
dc.contributor.authorYumuk, Volkan
dc.contributor.authorHaymana, Cem
dc.contributor.authorDemirci, Ibrahim
dc.contributor.authorBarcin, Cem
dc.contributor.authorKiyici, Sinem
dc.contributor.authorGuldiken, Sibel
dc.date.accessioned2024-06-12T11:09:30Z
dc.date.available2024-06-12T11:09:30Z
dc.date.issued2019
dc.departmentTrakya Üniversitesien_US
dc.description.abstractBackground: Obesity is the main obstacle for metabolic control in patients with type 2 diabetes. Turkey has the highest prevalence of obesity and type 2 diabetes in Europe. The effect of obesity on the metabolic control, and the macro-and microvascular complications of patients are not apparent. Objectives: This nationwide survey aimed to investigate the prevalence of overweight and obesity among patients with type 2 diabetes and to search for the impact of obesity on the metabolic control of these patients. We also investigated the independent associates of obesity in patients with type 2 diabetes. Methods: We consecutively enrolled patients who were under follow-up for at least 1 year in 69 tertiary healthcare units in 37 cities. The demographic, anthropometric, and clinical data including medications were recorded. Patients were excluded if they were pregnant, younger than 18 years, had decompensated liver disease, psychiatric disorders interfering with cognition or compliance, had bariatric surgery, or were undergoing renal replacement therapy. Results: Only 10% of patients with type 2 diabetes (n = 4,648) had normal body mass indexes (BMI), while the others were affected by overweight (31%) or obesity (59%). Women had a significantly higher prevalence of obesity (53.4 vs. 40%) and severe obesity (16.6 vs. 3.3%). Significant associations were present between high BMI levels and lower education levels, intake of insulin, antihypertensives and statins, poor metabolic control, or the presence of microvascular complications. Age, gender, level of education, smoking, and physical inactivity were the independent associates of obesity in patients with type 2 diabetes. Conclusion: The TEMD Obesity Study shows that obesity is a major determinant of the poor metabolic control in patients with type 2 diabetes. These results underline the importance of prevention and management of obesity to improve health care in patients with type 2 diabetes. Also, the results point out the independent sociodemographic and clinical associates of obesity, which should be the prior targets to overcome, in the national fight with obesity. (c) 2019 The Author(s) Published by S. Karger AG, Baselen_US
dc.description.sponsorshipTurkish Society of Endocrinology and Metabolismen_US
dc.description.sponsorshipThe TEMD Obesity Study was funded by the Turkish Society of Endocrinology and Metabolism. Automated BP monitors were provided by Sanovel A/S. The funding agencies had no role in the design and conduct of the study, the collection, management, analysis, and interpretation of the data, or the preparation, review, or approval of the manuscript.en_US
dc.identifier.doi10.1159/000496624
dc.identifier.endpage178en_US
dc.identifier.issn1662-4025
dc.identifier.issn1662-4033
dc.identifier.issue2en_US
dc.identifier.pmid30893706en_US
dc.identifier.scopus2-s2.0-85063411355en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage167en_US
dc.identifier.urihttps://doi.org/10.1159/000496624
dc.identifier.urihttps://hdl.handle.net/20.500.14551/22836
dc.identifier.volume12en_US
dc.identifier.wosWOS:000468937100005en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherKargeren_US
dc.relation.ispartofObesity Factsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectObesityen_US
dc.subjectType 2 Diabetesen_US
dc.subjectHba1cen_US
dc.subjectBlood Pressureen_US
dc.subjectLipid Metabolismen_US
dc.subjectCardiovascular Risken_US
dc.subjectBlood-Pressureen_US
dc.subjectSmokingen_US
dc.subjectDiseaseen_US
dc.subjectWeighten_US
dc.subjectAssociationen_US
dc.subjectPrevalenceen_US
dc.subjectAttainmenten_US
dc.subjectOverweighten_US
dc.titleImpact of Obesity on the Metabolic Control of Type 2 Diabetes: Results of the Turkish Nationwide Survey of Glycemic and Other Metabolic Parameters of Patients with Diabetes Mellitus (TEMD Obesity Study)en_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu